Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring
A rapid and selective UPLC-DAD method was developed and validated for simultaneous analysis of the novel two-drug combination Darvoni® for the treatment of HCV: Sofosbuvir (SF)/Daclatasvir (DC) in human plasma using Ledipasvir as internal standard (IS) where the extraction process was conducted usin...
Saved in:
Main Authors: | Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Analytical Chemistry |
Online Access: | http://dx.doi.org/10.1155/2018/6535816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients
by: Juferdy Kurniawan, et al.
Published: (2024-10-01) -
Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study
by: Hanan M. Fayed, et al.
Published: (2019-01-01) -
Validation of Colchicine Assay Method for Therapeutic Drug Monitoring in Human Plasma
by: Fadime Canbolat
Published: (2022-12-01) -
Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study
by: Li X, et al.
Published: (2025-02-01) -
Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
by: Tulsidas Mishra, et al.
Published: (2014-01-01)